HIGHLIGHTS
- who: Joohyun Hong et al. from the Division of Hematology and Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, have published the research work: Subsequent Systemic Therapy following Platinum and Immune Checkpoint Inhibitors in Metastatic Urothelial Carcinoma, in the Journal: Biomedicines 2022, 2005 of /2022/
- future: As randomized controlled clinical trials are sparse in this setting the authors performed the present retrospective analysis to develop improved therapeutic strategies for patients with mUC enhance patient counseling and generate hypotheses for future studies.
SUMMARY
Over the past two decades . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.